ZD1839 (IRESSA), an EGFR‐selective tyrosine kinase inhibitor, enhances taxane activity in bcl‐2 overexpressing, multidrug‐resistant MCF‐7 ADR human breast cancer cells
暂无分享,去创建一个
G. Zupi | G. Tortora | F. Ciardiello | D. Del Bufalo | A. Bianco | A. Biroccio | R. Caputo | G. Borriello